ClinicalTrials.govpublic full text
FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer
esophageal cancer, gastric cancer, bay 73-4506 (regorafenib), fluorouracil, leucovorin, oxaliplatin, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 968955
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.